https://www.marketscreener.com/quote/stock/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-U-S-infectious-disease-group-backs-Gilead-s-remdesivir-for-COVID-19-treatment-31849783/?utm_source=telegram&utm_medium=social&utm_campaign=share